Cargando…

Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities

Several different signaling pathways and molecular mechanisms have been identified as responsible for controlling critical functions in human cancer cells, such as selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Dongliao, Hu, Zhigang, Xu, Xinyang, Dai, Xiaoyan, Liu, Ziyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486121/
https://www.ncbi.nlm.nih.gov/pubmed/36122506
http://dx.doi.org/10.1016/j.tranon.2022.101510
_version_ 1784792208829841408
author Fu, Dongliao
Hu, Zhigang
Xu, Xinyang
Dai, Xiaoyan
Liu, Ziyi
author_facet Fu, Dongliao
Hu, Zhigang
Xu, Xinyang
Dai, Xiaoyan
Liu, Ziyi
author_sort Fu, Dongliao
collection PubMed
description Several different signaling pathways and molecular mechanisms have been identified as responsible for controlling critical functions in human cancer cells, such as selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasis, metabolic rewiring, an abetting microenvironment, and immune modulation. This concise summary will provide a selective review of recent studies of key signal transduction pathways, including mitogen-activated protein kinase (MAPK) pathway, Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling, and Wnt/β-catenin signaling pathway, which are altered in cancer cells, as the novel and promising therapeutic targets.
format Online
Article
Text
id pubmed-9486121
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-94861212022-09-30 Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities Fu, Dongliao Hu, Zhigang Xu, Xinyang Dai, Xiaoyan Liu, Ziyi Transl Oncol Commentary Several different signaling pathways and molecular mechanisms have been identified as responsible for controlling critical functions in human cancer cells, such as selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasis, metabolic rewiring, an abetting microenvironment, and immune modulation. This concise summary will provide a selective review of recent studies of key signal transduction pathways, including mitogen-activated protein kinase (MAPK) pathway, Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling, and Wnt/β-catenin signaling pathway, which are altered in cancer cells, as the novel and promising therapeutic targets. Neoplasia Press 2022-09-16 /pmc/articles/PMC9486121/ /pubmed/36122506 http://dx.doi.org/10.1016/j.tranon.2022.101510 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Fu, Dongliao
Hu, Zhigang
Xu, Xinyang
Dai, Xiaoyan
Liu, Ziyi
Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
title Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
title_full Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
title_fullStr Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
title_full_unstemmed Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
title_short Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
title_sort key signal transduction pathways and crosstalk in cancer: biological and therapeutic opportunities
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486121/
https://www.ncbi.nlm.nih.gov/pubmed/36122506
http://dx.doi.org/10.1016/j.tranon.2022.101510
work_keys_str_mv AT fudongliao keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities
AT huzhigang keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities
AT xuxinyang keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities
AT daixiaoyan keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities
AT liuziyi keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities